High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Indian J Med Microbiol
; 2009 Jan-Mar; 27(1): 48-50
Article
en En
| IMSEAR
| ID: sea-53539
ABSTRACT
Serum samples from 465 subjects aged between 1 and 25 years were tested for antibody against hepatitis A virus (HAV) [anti-HAV IgG and IgM] to determine the seroprevalence of HAV antibody and do a cost-benefit analysis for decision making about vaccination against HAV among the general population of Bangladesh. A high prevalence of anti-HAV (74.8%) was observed in the study population; the whole study population was found positive for anti-HAV by the age of 25 years. On performing the cost-benefit analysis, it was found that the cost for vaccination with screening for anti-HAV was almost three times cheaper than vaccination without screening. Thus, in the present socioeconomic condition of Bangladesh, a policy based on screening for HAV antibody before vaccination is recommended.
Texto completo:
1
Índice:
IMSEAR
Asunto principal:
Bangladesh
/
Femenino
/
Humanos
/
Masculino
/
Inmunoglobulina G
/
Inmunoglobulina M
/
Estudios Seroepidemiológicos
/
Niño
/
Preescolar
/
Control de Enfermedades Transmisibles
Tipo de estudio:
Diagnostic_studies
/
Prevalence_studies
/
Risk_factors_studies
/
Screening_studies
País/Región como asunto:
Asia
Idioma:
En
Revista:
Indian J Med Microbiol
Asunto de la revista:
Microbiology
Año:
2009
Tipo del documento:
Article